Fear of litigation not cause of skyrocketing US health care costs, says Public Citizen

1 April 2011

In the vast majority of circumstances, doctors act based on their clinical judgment and other factors, not based on liability concerns, according to a report released by US consumer advocacy Public Citizen. Common claims about “defensive medicine,” a term for doctors performing unnecessary tests and procedures due to the fear of litigation, are wildly overblown, it claims.

Much stronger evidence points to other causes of unnecessary tests and procedures, such as a fee-for-service system that pays providers more for every additional test and procedure, said Public Citizen. The report, “Defensive Medicine: The Doctored Crisis,” comes as both congressional Republicans and President Barack Obama have called for new policies on medical liability.

Republicans in the US House of Representatives are pushing through the legislative process a sweeping bill, the Help Efficient Accessible, Low-cost, Timely Healthcare Act of 2011, or HR 5, that would let all the players in the medical industry - doctors, hospitals, pharmaceutical companies, nursing home providers and the medical device industry - off the hook when they injure or kill people with recklessness.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical